This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on May 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Pharmaceutical Products for CDER Research Studies - IDIQ

Closed

75F40126Q132721Federal

Submission Closed05/15/2026, 06:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

LEVOFLOXACIN TABLETThe contract pertains to the procurement of Levofloxacin tablets, identified by NSN/Part Number 6505-01-444-6632, with a purchase quantity of one unit under request number 7017178498. The solicitation, designated SPE2DP-26-T-3807, was issued by the Defense Logistics Agency on behalf of the Department of Defense with a posting date of June 15, 2026, and a response deadline set for June 22, 2026. This solicitation is categorized as a federal opportunity without specific set-aside conditions or NAICS code information provided. The contract will be performed within the United States, although exact location details are unspecified. The Defense Logistics Agency is managing the acquisition, and the solicitation details are accessible via a designated DIBBS URL for interested parties.

Defense Logistics Agency

POSTED

DEADLINE

Supply of Non-Substitutable Pharmaceutical IngredientsThis contract involves the supply of proprietary, branded pharmaceutical components including TrophAmin®, Plenamine, Nutrilipid®, and SMOF Lipid®, which are essential ingredients used in Total Parenteral Nutrition (TPN) formulations. The contract emphasizes full traceability and compliance with regulatory standards to ensure the safety and quality of these non-substitutable pharmaceutical ingredients. The procurement is managed by the Defense Health Agency Hcd West under the Department of Defense, reflecting the critical nature of these supplies for health services within defense operations. The solicitation was posted on June 15, 2026, with a response deadline set for June 30, 2026. The contract is classified as a subcontract under the NAICS code 325412, which pertains to pharmaceutical manufacturing. The place of performance falls within the 98431 zip code area, though specific city or state details are not disclosed. This contract supports the continued availability of specialized pharmaceutical components necessary for patient nutrition and care in military healthcare settings.

Defense Health Agency Hcd West

POSTED

DEADLINE

Custom Sterile Compounding of Total Parenteral Nutrition (TPN) FormulationsThe contract involves the manufacture and delivery of patient-specific, sterile Total Parenteral Nutrition (TPN) formulations, including branded products such as TrophAmin®, Plenamine, Nutrilipid®, and SMOF Lipid®. These formulations must be provided in volumes ranging from 1000 to over 3000 mL, with an absolute requirement for zero tolerance for deviations, ensuring strict adherence to quality and safety standards. This precision is critical given the nature of the products and their use in patient care. Administered by the Defense Health Agency Hcd West under the Department of Defense, the contract is categorized under NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing. The contract is structured as a subcontract with a deadline for responses set for June 30, 2026. Performance is designated for an area identified by the zip code 98431. The contract underscores the importance of reliable, high-quality sterile compounding to meet defense health requirements with strict compliance to specifications and timelines.

Defense Health Agency Hcd West

POSTED

DEADLINE

Sole Source Total Parenteral Nutrition (TPN) solutions, including TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid same-day delivery, seven days a weekThis contract involves the sole source procurement of Total Parenteral Nutrition (TPN) solutions, specifically including products such as TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid. The key requirement is for same-day delivery, seven days a week, ensuring continuous availability of these critical nutritional solutions. The solicitation number is HT941026N0069, with the notice posted on June 15, 2026, and a response deadline set for June 30, 2026. The contract falls under the NAICS code 325412, associated with pharmaceutical preparation manufacturing, and is issued by the Defense Health Agency located at Camp Pendleton, California. The place of performance is identified within Washington state, ZIP code 98431, indicating where the deliveries or contract services will be conducted. There is no set-aside designation for this procurement, reflecting an open competitive strategy or a direct sole-source justification. Primary and secondary points of contact are provided for further inquiries, with the primary contact being CHA-ON Gordon. The contract aims to support the Department of Defense’s ongoing medical and nutritional needs for personnel, emphasizing timely and reliable supply chain delivery for essential TPN products.

Defense Health Agency Hcd West

POSTED

DEADLINE

6505--Lab Supplies | Radiopharm | 5-Year Indefinite Delivery/Indefinite Quantity (IDIQ) | VA Pittsburgh Healthcare SystemThe contract solicits bids for the supply of laboratory materials related to radiopharmaceuticals under a five-year indefinite delivery, indefinite quantity (IDIQ) agreement for the VA Pittsburgh Healthcare System. The solicitation, identified by the number 36C24426Q0669, invites vendors to provide these specialized lab supplies consistent with NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The Department of Veterans Affairs, specifically the 244-NETWORK Contract Office 4 located in Pittsburgh, Pennsylvania, is managing this procurement. Vendors interested in participating must submit their proposals by July 10, 2026, with the solicitation having been posted on June 12, 2026. The contract aims to ensure a steady and flexible supply of radiopharmaceutical lab materials to support healthcare operations over a multi-year period, accommodating variable quantities as needed. The primary point of contact for this contract is Christa L. Stine, a contract specialist reachable via email, facilitating communication and clarifications throughout the solicitation process.

244-NETWORK Contract Office 4 (36C244)

POSTED

5 days ago

DEADLINE

in 27 days

AI Contract Overview

The contract pertains to the procurement of pharmaceutical products for CDER research studies under an Indefinite Delivery Indefinite Quantity (IDIQ) arrangement. The current or most recent vendor is WE Pharma, LLC, with the previous contract number being 75F40120D00032 and the solicitation number FDASOL1222072. The prior contract had a ceiling value of $9,500,000, with a performance period from September 30, 2020, to September 29, 2025. Historical pricing details are not disclosed as part of this solicitation but may be requested through the Freedom of Information Act (FOIA) process. The new solicitation, identified as 75F40126Q132721, was posted on May 11, 2026, with a response deadline of May 15, 2026. It is managed by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, located in Rockville, Maryland. An amendment dated May 4, 2026, updated the Small Business Subcontracting Plan (SBCX) link, and no publicly available award documentation is currently known. The contract falls under NAICS code 325412, indicating pharmaceutical manufacturing, and is structured as a combined synopsis/solicitation to solicit offers for continued pharmaceutical product support to CDER research initiatives.

General Info

Procurement of pharmaceutical products for CDER research under IDIQ contract, managed by FDA.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

MD, USA

Set-Aside

NONE

Documents

(3)

Attachment+1+Comprehensive+Drug+Products+list.xlsx

XLSX

Sol+Doc+combined+synopsis-solicitation+75F40126Q132721.pdf

PDF

Amendment+1+Sol+Doc+combined+synopsis-solicitation+75F40126Q132721.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Timeline

2 updates

PhaseClosed

Amendment 1May 4

Contract was updated

PostedMay 11

Combined Synopsis

Amendment 2May 11

Contract was updated

Response DeadlineMay 15

Deadline has passed

Submission Closed

05/15/2026, 06:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs

Contacts1 person available

OfficeRockville, MD, 20852, USA

Organization / Agency

Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Office AddressRockville, MD, 20852, USA

Contacts

Nick Sartain

contact@example.gov

+1 (555) 000-0000

Full Description

5/11/2026:

Questions and answers:

Current or most recent incumbent contractor/vendor name

Response: WE Pharma, LLC

Previous contract number and/or SAM.gov solicitation number

Response: Previous contract number 75F40120D00032 and solicitation number FDASOL1222072.

Contract award value or estimated annual spend

Response: The prior IDIQ Ceiling was $9,500,000.00.

Historical pricing information or awarded pricing structure

Response: Historical pricing information and awarded pricing structure are not being provided as part of this solicitation Q&A. Requests for agency records on pricing may be submitted through the applicable FOIA process and will be reviewed for releasability.

Period of performance of the incumbent contract

Response: 9/30/2020 to 9/29/2025.

Any publicly available award documentation or reference links

Response: None that we are aware of.

5/4/2026: See attached amendment 1 which updates the SBCX link for the subcontracting plan.

See attached combined synopsis/solicitation.